109 related articles for article (PubMed ID: 16610259)
1. [Bronchiectasis worsening by p-ANCA (bactericidal/permeability-increasing protein) positive vasculitis. A case report and review of the literature].
Benucci M; Nenci G; Taccetti G; Rosso A; Beltrame C; Cappelletti C; Manfredi M
Ann Ital Med Int; 2005; 20(4):258-61. PubMed ID: 16610259
[TBL] [Abstract][Full Text] [Related]
2. Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody.
Matsuyama W; Wakimoto J; Watanabe A; Kubota I; Hirotsu Y; Mizoguchi A; Iwami F; Kawabata M; Osame M
Intern Med; 1999 Oct; 38(10):813-6. PubMed ID: 10526946
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.
Emmi L; Chatzipetrou A
Ann Ital Med Int; 2005; 20(4):205-8. PubMed ID: 16610250
[No Abstract] [Full Text] [Related]
4. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis.
Dorlöchter L; Carlsson M; Olafsdottir EJ; Røksund OD; Rosendahl K; Fluge G
J Cyst Fibros; 2004 Aug; 3(3):179-83. PubMed ID: 15463905
[TBL] [Abstract][Full Text] [Related]
5. [A case of p-ANCA positive necrotizing vasculitis associated with Graves' disease].
Aoki A; Suzuki H; Ohata T; Ohno S; Nagaoka S; Chiba J; Kanamaru T; Usuda Y
Ryumachi; 1995 Aug; 35(4):683-7. PubMed ID: 7482066
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.
Carlsson M; Eriksson L; Pressler T; Kornfält R; Mared L; Meyer P; Wiik A; Wieslander J; Segelmark M
J Cyst Fibros; 2007 May; 6(3):228-33. PubMed ID: 17166780
[TBL] [Abstract][Full Text] [Related]
7. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
Schultz H; Weiss J; Carroll SF; Gross WL
J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis.
Grypiotis P; Cozzi F; Ruffatti A
J Rheumatol; 2004 Jul; 31(7):1468-9. PubMed ID: 15229985
[No Abstract] [Full Text] [Related]
9. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI).
Schultz H
Autoimmun Rev; 2007 Mar; 6(4):223-7. PubMed ID: 17317612
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibody vasculitis associated with mycobacterium avium intracellulare infection.
Chaiamnuay S; Heck LW
J Rheumatol; 2005 Aug; 32(8):1610-2. PubMed ID: 16078343
[TBL] [Abstract][Full Text] [Related]
11. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
12. Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiency.
Mahadeva R; Zhao MH; Stewart S; Cary N; Flower C; Lockwood M; Shneerson J
Chest; 1997 Dec; 112(6):1699-701. PubMed ID: 9404779
[TBL] [Abstract][Full Text] [Related]
13. Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo.
Tabata H; Honda K; Moriyama T; Itabashi M; Taneda S; Takei T; Tanabe K; Teraoka S; Yamaguchi Y; Oda H; Nitta K
Clin Transplant; 2009 Aug; 23 Suppl 20():49-53. PubMed ID: 19594597
[TBL] [Abstract][Full Text] [Related]
14. [Antineutrophil cytoplasmic antibodies and associated diseases].
Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
[TBL] [Abstract][Full Text] [Related]
15. Systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies against bactericidal/permeability increasing protein.
Fukuhara A; Tanino Y; Sato S; Ishii T; Nikaido T; Kanazawa K; Saito J; Ishida T; Kanno M; Watanabe T; Munakata M
Intern Med; 2013; 52(10):1095-9. PubMed ID: 23676597
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
Almroth G; Berlin G; Andersson B; Hahn-Zoric M
Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis.
Son D; Kanda H; Yamaguchi A; Kawabata K; Kawakami T; Kubo K; Higashihara M; Shimizu J; Uozaki H; Kuramochi S; Misaki Y; Takeuchi F; Yamamoto K
J Nephrol; 2009; 22(3):417-20. PubMed ID: 19557721
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of minocycline-induced vasculitis].
Sakai H; Komatsu S; Matsuo S; Iizuka H
Arerugi; 2002 Dec; 51(12):1153-8. PubMed ID: 12522319
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
Lin W; Chen M; Zhao MH
Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]